glp-1 drugs chemically different clinically similar GIPR/GLP-1R dual agonist therapies for diabetes and weight loss—chemistry, physiology, and clinical applications The current range of weight-loss

While glucagon-like peptide-1 (GLP-1) medications are known to improve sleep apnea in patients with obesity, the study found that not all patients benefit equally

A study in The New England Journal of Medicine found that 59 percent of patients with NASH (non-alcoholic steatohepatitis) who took a high dose of semaglutide for 72 weeks saw improvement without worsening of fibrosis (or scarring)

Hair testing is more commonly used in certain high-security employment contexts, legal proceedings, and substance abuse monitoring programs

Aronne LJ, Wadden TA, Peterson C, Winslow D, Odeh S, Gadde KM

The glucagon receptor activation drives hepatic fat oxidation in ways that dual agonists do not replicate

Edward, who lives in New Jersey, says he would not have started the regimen if he had known he could become blind from it